Abivax reported cash from operations of -$0.06B and free cash flow of -$0.06B for the quarter ended Mar 2026, down 69.0% year over year. This cash flow statement covers 11 quarters of results from Dec 2022 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2022 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Net Income | -0.07B | -0.14B | 0.05B | 0.04B | 0.06B | 188.19B | 0.06B | 0.05B | 0.18B | 390.94B | 0.06B |
| Share-based Compensation | 0.01B | 0.01B | 0.00B | 21.59B | 0.00B | 0.01B | 0.01B | 41.18B | 0.03B | ||
| Deferred Taxes | -0.00B | 0.00B | -0.00B | 1.88B | 0.00B | 0.00B | 0.03B | 0.80B | |||
| Cash from Discontinued Operations | -166.04B | -0.04B | -191.63B | -0.05B | |||||||
| Gains from Investment Securities | -0.00B | 0.00B | 0.00B | ||||||||
| Cash from Operations | -0.04B | -0.05B | -0.04B | -164.51B | -0.04B | -0.04B | -0.08B | -187.40B | -0.06B | ||
| Depreciation, Depletion & Amortization | |||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.00B | 0.00B | 0.00B | 1.17B | 0.00B | 0.00B | 0.00B | 1.25B | 0.00B | ||
| Change in Working Capital | |||||||||||
| Change in Receivables | -0.00B | 0.01B | -0.00B | 4.90B | -0.00B | 0.01B | -0.01B | 8.20B | -0.00B | ||
| Change in Account Payables | 0.01B | -0.02B | 0.02B | -3.68B | 0.01B | 0.00B | -0.03B | -7.21B | -0.01B | ||
| Change in Accured Expenses | -0.00B | 0.00B | -0.00B | -1.59B | -0.00B | 0.00B | 0.01B | 2.45B | 0.01B | ||
| Other Working Capital Changes | -0.00B | -0.00B | -0.00B | -0.49B | -0.00B | -0.00B | -0.00B | -1.06B | -0.00B | ||
| Investing Activities | |||||||||||
| Capital Expenditures | -0.00B | -0.00B | -0.00B | -0.68B | -0.00B | -0.00B | 0.00B | -0.17B | -0.00B | ||
| Change in Intangibles | -0.00B | ||||||||||
| Cash from Investing Activities | 0.00B | 0.01B | 0.00B | 16.83B | 0.00B | 0.00B | 0.00B | -9.54B | 0.00B | ||
| Financing Activities | |||||||||||
| Other financing activities | 0.00B | 0.00B | 0.00B | 0.26B | 0.00B | 0.00B | 0.35B | ||||
| Debt Issuance and Repayment | |||||||||||
| Long-Term Debt Issuances | 0.03B | 0.03B | -0.00B | 51.18B | |||||||
| Long-Term Debt Repayments | -0.00B | -0.00B | -0.00B | -9.34B | -0.00B | 0.00B | -0.01B | -62.75B | |||
| Misc. | |||||||||||
| Cash from Financing Activities | 0.02B | 0.02B | -0.01B | 30.11B | -0.01B | -0.01B | 0.71B | 636.41B | 0.00B | ||
| Exchange Rate Effect | 0.00B | 0.00B | -0.00B | 2.55B | -0.00B | -0.00B | 0.01B | -11.92B | 0.01B | ||
| Change in Cash | -0.01B | -0.02B | -0.05B | -115.03B | -0.04B | -0.05B | 0.62B | 433.05B | -0.05B | ||
| Beginning Cash Balance | 0.27B | ||||||||||
| Free Cash Flow | -0.04B | -0.05B | -0.04B | -163.83B | -0.03B | -0.04B | -0.08B | -187.24B | -0.06B | ||
| Net Cash Flow | -0.01B | -0.02B | -0.04B | -117.58B | -0.04B | -0.05B | 0.63B | 439.46B | -0.06B |